Ginkgo Bioworks Holdings ROA 2020-2022 | DNA
Current and historical return on assets (ROA) values for Ginkgo Bioworks Holdings (DNA) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Ginkgo Bioworks Holdings ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2022-12-31 |
$-2.11B |
$2.54B |
-99.55% |
| 2022-09-30 |
$-3.53B |
$1.87B |
-176.63% |
| 2022-06-30 |
$-2.96B |
$1.99B |
-143.24% |
| 2022-03-31 |
$-2.35B |
$2.06B |
-117.31% |
| 2021-12-31 |
$-1.83B |
$2.07B |
-95.41% |
| 2021-06-30 |
$-0.15B |
$1.73B |
-17.83% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.549B |
$0.478B |
|
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
|
